Target Group (CBDY) Stock Analysis & Winston Score

Target Group Inc. (CBDY) is a small Canadian pharmaceutical company that makes and sells generic and specialty drugs. It focuses on producing oral solid dosage forms — things like tablets and capsules — and sells primarily to pharmacies, wholesalers, and healthcare distributors. The company operates in the generic drug manufacturing space, where products are copies of brand-name medicines sold at lower prices. Target Group earns revenue by selling its manufactured drug products to customers across Canada, with some exposure to export markets. It is a very small company, with a market cap near zero, and it competes in a crowded generic drug industry where larger players have significant cost and scale advantages. The company is currently operating at a loss, as its operating margin is negative, meaning it spends more running the business than it earns from sales. The main risk is whether it can grow revenue fast enough to cover its costs and reach consistent profitability before running low on resources.